Atlas Trials

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

Clinical trial NCT03813407 · RECRUITING

Trial details

NCT number
NCT03813407
Sponsor
AstraZeneca
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperkalaemia
Start date
2019-04-02
Primary completion
2030-02-21
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.